132 related articles for article (PubMed ID: 29374231)
1. Modulation of oncogenic miRNA biogenesis using functionalized polyamines.
Staedel C; Tran TPA; Giraud J; Darfeuille F; Di Giorgio A; Tourasse NJ; Salin F; Uriac P; Duca M
Sci Rep; 2018 Jan; 8(1):1667. PubMed ID: 29374231
[TBL] [Abstract][Full Text] [Related]
2. Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.
Vo DD; Staedel C; Zehnacker L; Benhida R; Darfeuille F; Duca M
ACS Chem Biol; 2014 Mar; 9(3):711-21. PubMed ID: 24359019
[TBL] [Abstract][Full Text] [Related]
3. Repression of MicroRNA-372 by Arsenic Sulphide Inhibits Prostate Cancer Cell Proliferation and Migration through Regulation of large tumour suppressor kinase 2.
Cao H; Feng Y; Chen L
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):256-263. PubMed ID: 27730751
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
[TBL] [Abstract][Full Text] [Related]
5. Building of neomycin-nucleobase-amino acid conjugates for the inhibition of oncogenic miRNAs biogenesis.
Vo DD; Becquart C; Tran TPA; Di Giorgio A; Darfeuille F; Staedel C; Duca M
Org Biomol Chem; 2018 Aug; 16(34):6262-6274. PubMed ID: 30116813
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
[TBL] [Abstract][Full Text] [Related]
7. Role of pri-miRNA tertiary structure in miR-17~92 miRNA biogenesis.
Chaulk SG; Thede GL; Kent OA; Xu Z; Gesner EM; Veldhoen RA; Khanna SK; Goping IS; MacMillan AM; Mendell JT; Young HS; Fahlman RP; Glover JN
RNA Biol; 2011; 8(6):1105-14. PubMed ID: 21955497
[TBL] [Abstract][Full Text] [Related]
8. AC1MMYR2, an inhibitor of dicer-mediated biogenesis of Oncomir miR-21, reverses epithelial-mesenchymal transition and suppresses tumor growth and progression.
Shi Z; Zhang J; Qian X; Han L; Zhang K; Chen L; Liu J; Ren Y; Yang M; Zhang A; Pu P; Kang C
Cancer Res; 2013 Sep; 73(17):5519-31. PubMed ID: 23811941
[TBL] [Abstract][Full Text] [Related]
9. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J
Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808
[TBL] [Abstract][Full Text] [Related]
10. Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.
Melo S; Villanueva A; Moutinho C; Davalos V; Spizzo R; Ivan C; Rossi S; Setien F; Casanovas O; Simo-Riudalbas L; Carmona J; Carrere J; Vidal A; Aytes A; Puertas S; Ropero S; Kalluri R; Croce CM; Calin GA; Esteller M
Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4394-9. PubMed ID: 21368194
[TBL] [Abstract][Full Text] [Related]
11. A Macrocyclic Peptide Ligand Binds the Oncogenic MicroRNA-21 Precursor and Suppresses Dicer Processing.
Shortridge MD; Walker MJ; Pavelitz T; Chen Y; Yang W; Varani G
ACS Chem Biol; 2017 Jun; 12(6):1611-1620. PubMed ID: 28437065
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Targeting Anti-MicroRNA-155 Delivery Based on Biodegradable Poly(ester amine) and Hyaluronic Acid Shielding for Lung Cancer Therapy.
Yang Y; Jia Y; Xiao Y; Hao Y; Zhang L; Chen X; He J; Zhao Y; Qian Z
Chemphyschem; 2018 Aug; 19(16):2058-2069. PubMed ID: 29488305
[TBL] [Abstract][Full Text] [Related]
13. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2.
Yang X; Yu J; Yin J; Xiang Q; Tang H; Lei X
Pharmazie; 2012 Jul; 67(7):645-51. PubMed ID: 22888524
[TBL] [Abstract][Full Text] [Related]
14. Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing.
Maiti M; Nauwelaerts K; Herdewijn P
Bioorg Med Chem Lett; 2012 Feb; 22(4):1709-11. PubMed ID: 22257890
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer.
Zhong M; Ma X; Sun C; Chen L
Chem Biol Interact; 2010 Mar; 184(3):431-8. PubMed ID: 20097187
[TBL] [Abstract][Full Text] [Related]
16. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK).
Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X
Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365
[TBL] [Abstract][Full Text] [Related]
19. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.
Xia Y; Gao Y
Biochem Biophys Res Commun; 2014 May; 447(3):446-51. PubMed ID: 24735543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
